Monash Ageing Research Centre (MONARC), Monash University, Melbourne, Victoria, Australia.
Allied Health, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Australas J Ageing. 2022 Dec;41(4):e356-e363. doi: 10.1111/ajag.13043. Epub 2022 Feb 15.
General practitioners face many barriers to deprescribing psychotropic medications in people with dementia in nursing homes, including a lack of knowledge about their medication histories. This study explored the knowledge of family members about residents' medications and their willingness to support deprescribing.
Sixty-six family members of residents from seven residential aged care facilities participated in this cross-sectional study. Participation involved nomination of recognised medications, rating their effectiveness and rating level of support for deprescribing.
Fifty-five per cent of medications were recognised by family members; significantly fewer psychotropics were recognised than non-psychotropic medications. Though rated as just as effective, support for deprescribing psychotropics was significantly higher. Most family members were agreeable to deprescribing with general practitioner support.
Although there is a gap in family members' knowledge about psychotropic medications, overall they are supportive of deprescribing. Findings emphasise the need for psychoeducation among family members. Providing family members with a list of prescribed medications, specifying the type of and reason for prescription and side effects of each, is recommended to facilitate their advocacy for deprescribing on behalf of nursing home residents.
全科医生在养老院为痴呆症患者减少精神药物治疗时面临许多障碍,包括对其用药史缺乏了解。本研究探讨了家属对居民用药情况的了解程度及其对减少用药的支持意愿。
来自七个养老院的 66 名居民的家属参加了这项横断面研究。参与包括提名认可的药物、评估其有效性和对减少用药的支持程度。
55%的药物被家属识别;识别出的精神药物明显少于非精神药物。尽管被认为同样有效,但对减少精神药物的支持率明显更高。大多数家属都同意在全科医生的支持下减少用药。
尽管家属对精神药物的了解存在差距,但总体上他们支持减少用药。研究结果强调了对家属进行心理教育的必要性。建议向家属提供一份规定药物的清单,详细说明每种药物的类型、用途和处方的原因以及每种药物的副作用,以方便他们代表养老院居民进行减少用药的倡导。